Open Access

Marketing Researches of Market of Medications of Neuroprotective Action in Ukraine


Cite

[1] Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors: systematic analysis of population health data. Lancet 2006; 367: 1747–1757. 10.1016/S0140-6736(06)68770-9Search in Google Scholar

[2] Marunich VV, Ipatov AV, Korobkin UI et al. Basic indicators of disability and medical social expert commissions of Ukraine in 2010: analytical and information guide. In: Yemets IM, editor. Dnipropetrovsk: Porogi, 2011: 135. Search in Google Scholar

[3] Annual report on the state of health of Ukraine and sanitary epidemiological situation in 2010. In: Anishchenko OJ, editor. Kyiv, Ministry of Health of Ukraine, 2011: 461. Search in Google Scholar

[4] Brainin M, Bornstein N, Boysen G, Demarin V. Acute neurological stroke care in europe: results of the european stroke care inventory. Eur J Neurol 2000; 7: 5–10. 10.1046/j.1468-1331.2000.007001005.x10809909Search in Google Scholar

[5] Mureshanu DF. Integrated approach to neuroprotection and neuroplasticity in stroke therapy. International Neurol J 2007; 6 (16): 63–66. Search in Google Scholar

[6] Alonso de Lecinana M, Diez-Tejedor E, Gutierrez M, Guerrero S, Carceller F, Roda JM. New goals in ischemic stroke therapy: the experimental approach – harmonizing science with practice. Cerebrovasc Dis 2005; 20 (Suppl 2): 159–168. 10.1159/00008937016327267Search in Google Scholar

[7] Information retrieval system “State Register of drugs of Ukraine”. http://www.drlz.kiev.ua. Accessed January 10, 2013 Search in Google Scholar

[8] Kovalenko VN, Viktorova AP. Compendium 2009 - drugs. Kiev: Morion, 2009: 2270.Search in Google Scholar

ISSN:
0301-2298
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Pharmacy, other